There is a new higher oral dose semaglutide that targets adults with obesity, regardless if they have type 2 diabetes
Both are FDA-approved, well-studied, and produce significant weight loss results while retatrutide completes the approval process
Key scientific messages on the topic of dietary sugars and addiction
Although GLP-1 has been studied for decades, public interest has skyrocketed with the introduction of medications such as Ozempic, Wegovy, and Mounjaro, which target this hormone to help manage blood sugars and support weight loss
Given their effectiveness and expanding range of benefits, it is no wonder that GLP-1 receptor agonists are becoming an increasingly popular choice for both doctors and patients alike
In the journey toward a healthier weight and life, you have more options today than ever before